Marinus Announces Ganaxolone Orphan Epilepsy Program Updates Including Planned Clinical Program in Tuberous Sclerosis Complex

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. META
9. AMC
10. COHR

Go back to Marinus Announces Ganaxolone Orphan Epilepsy Program Updates Including Planned Clinical Program in Tuberous Sclerosis Complex
(NASDAQ: MRNS) Delayed: 0.55 --0 (-0%)
Previous Close $0.55    52 Week High $8.12 
Open $0.55    52 Week Low $1.02 
Day High $0.55    P/E N/A 
Day Low $0.55    EPS $0.00 
Volume 300